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Abstract
The objective of this study was to evaluate the osteogenic differentiation of adipose-derived mesenchymal stem cells (ADSCs) into 
polycaprolactone scaffold (PCL). After ADSC characterization, cells were seeded onto the scaffolds and incubated with basal or 
osteogenic differentiating medium to MTT assay and osteogenesis evaluation. MTT cell viability assay showed that cell-seeded 
scaffolds cultured in both mediums presented formazan cristals formed as a result of the presence of viable cells. The osteogenic 
assay showed that cell-seeded PCL scaffolds cultured in osteogenic medium presented significantly greater amount of staining dye
when compared to basal medium and scaffold without cells. The PCL scaffold have great potential to be used associated to ADSCs
in Tissue Engineering to bone tissue regeneration
.
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1. Introduction
Bone defects assume importance in growing prevalence of chronic health conditions since fractures and critical 
defects should increase as the population ages [1]. Conventional treatments require transplantation and extremely 
invasive approaches, therefore the challenge of developing new therapies and treatments is still growing [1,2]. A 
promising approach is to obtain tissue or organized differentiated cell culture in laboratory using scaffolds for the 
growth and/or differentiation of cells and factors that enable a suitable neovascularization and osteoinduction for 
grafting [2,3].
The development of medical devices has been essential for improving the quality of life and reducing global 
healthcare costs. Tissue Engineering (TE) has emerged to combine 3D-scaffolds with living cells to promote the repair 
and/or regeneration of tissues [4,5]. The ideal scaffold should be biocompatible, biodegradable into nontoxic products 
with a controlled degradation rate and possess an optimized micro/macrostructural feature capable of guarantying 
simultaneously both adequate vascularization and sufficient mechanical strength to withstand stresses in the host tissue 
environment and allow cell attachment, proliferation and differentiation [3, 5, 6].
The basic principle about TE involves the use of an appropriate cell source and a biocompatible and biodegradable 
scaffold to produce a construct that structurally and functionally mimic the target tissue [7]. Mesenchymal stem cells 
(MSCs) are a rare cell type that were originally found in the bone marrow during the 1960s [8]. These cells have since 
become an attractive source of stem cells for tissue engineering applications [9]. Their potential applications are a 
direct result of their ability to differentiate into cells of the mesodermal lineage, including adipocytes, chondrocytes 
and osteoblasts [10, 11]. One of the interesting alternative sources of MSCs is adipose tissue harvested through 
liposuction or surgery to remove fat tissue, a much less invasive method than bone marrow aspiration and has the 
advantage of being generally available in much larger quantities [12-16]. Adipose-derived mesenchymal stem cells 
(ADSCs) are phenotypically similar to bone marrow stem cells and are also capable of multilineage differentiation in 
addition to express less HLA markers than bone marrow stem cells. The HLA differences are also interesting as MSCs 
have been demonstrated to be nonimmunogenic and immunosuppressive in vitro and in vivo [17–19], and as ADSCs 
express less HLA, they may have more potential in transplantation.
The objective of this study was to evaluate the osteogenic differentiation of adipose-derived mesenchymal stem 
cells (ADSCs) into polycaprolactone scaffold (PCL) produced by 3D printing technologies.
2. Methods
2.1. Cell source and culture
The ADSCs were isolated from the lipoaspirates generated during elective surgeries or liposuction of patients in 
Ribeirão Preto Medical Hospital after obtaining informed consent from all patients and approval from the hospital 
ethics committee. The cell isolation method is based on extracellular matrix (ECM) digestion in 0.075% collagenase 
(SIGMA) for 30 minutes at 37°C according to previously established method [20]. Digestion was neutralized with 
Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen) containing 10% fetal bovine serum (FBS; Invitrogen). 
The digested adipose tissue was centrifuged and pellet was plated in tissue culture plate. ADSCs were cultured and 
expanded at 37oC under 5% CO2 using basic culture medium (containing Į -MEM, 10% fetal bovine serum, 1% 
antibiotic-antimycotic, 1% L-Glutamine 200mM, all Invitrogen). The medium was changed twice per week, and cells 
were passaged on reaching 80-90% confluence by the use of 0.25% trypsin-EDTA solution (from Invitrogen). During 
this study, only passages 3 up to 5 were used.
2.2. ADSC characterization and multilineage differentiation
FACSCalibur cytometer (BD, Becton-Dickson) was used with specific fluorescein-conjugated monoclonal 
antibodies including CD29, CD44, CD73, CD90, CD105 as positive ones and CD14, CD31, CD34, CD45, CD71, 
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CD144, CD11b, Anti-HLA as negative (all from B&D Bioscience). Adherent cells were harvested (n=4) and followed 
to incubation with antibodies for 20 minutes in a dark place, then washed twice with phosphate-buffered saline (PBS) 
and resuspended  in  PBS. Data were analyzed with Cellquest software and were presented as means of CD markers 
percentage values.
The potential of ADSCs to differentiate into osteoblasts and adipocytes was also confirmed in monolayer culture. 
To induce adipogenic differentiation (n=4), cultured cells were incubated in Į-MEM basic medium supplemented 
with 10ȝg/mL de insulina (Sigma-Aldrich), 100ȝM de indometacina (Sigma-Aldrich), and 1ȝM dexamethasone, all 
supplements from Sigma-Aldrich. To induce osteogenic differentiation (n=4FHOOVZHUHLQFXEDWHGLQĮ-MEM basic 
PHGLXPVXSSOHPHQWHGZLWKȝ0RIDVFRUELFDFLGDQGP0RIȕ-glycerophosphate, 0,5ȝ0RIGH[DPHWKDVRQHDOO
also from Sigma-Aldrich. The mediums of both cultures were replaced every 3 days during 21 days. Sudan IV and 
Alizarin Red-S (ARS) histological staining evaluated the presence of cell differentiation, respectively.  
2.3 Scaffolds design and production 
Manchester Biomanufacturing Centre (MBC) has a wide range of Additive Manufacturing systems for the 
production of 3D scaffolds in layer by layer fashion. In this project, it was used 3D printing technologies, namely 
Bioplotter, to produce customized 3D bioactive scaffolds for bone tissue engineering. The production process of
Polycaprolactone (PCL) 3D scaffolds was based in the generation of a 3D solid model in Computer Aided Design 
software followed by the definition of process and architecture parameters using the machine specific software [21-
23]. The PLC scaffold used in this study is showed in Figure 1. 
Figure 1. PCL scaffold produced in MBC used in this study.
2.4. Cell seeding
Scaffolds (1cm3) were placed in 24-well tissue culture plates using fibrin sealant 3:1 (fibrinogen: thrombin) to 
maintain them on the bottom of the wells. After that, 1x105 ADSCs were seeded onto the scaffolds forming the cell-
seeded scaffolds cultured in basic Į-MEM culture medium. The cell-seeded scaffolds were incubated in standard 
conditions for 4h to allow cells to diffuse into and adhere to the scaffold before the addition of 1 mL of fresh basic 
culture medium or osteo-differentiating medium as described above. All cell-seeded scaffolds were maintained in a 
humidified incubator at 37oC and 5% CO2 with medium changes every 3 days.
2.5. Cell viability
Cell-seeded scaffolds in 24-well tissue culture plates were cultured in both mediums for 14 days. The mitochondrial 
activity of ADSCs into the scaffold was determined with the MTT colorimetric assay. This test can detect the 
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conversion of 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (Sigma, USA) to formazan crystals. 
Cultures were incubated in the presence of 0.5 mg/mL 3-(4,5-Dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide 
(MTT) for 3 h. Water insoluble formazan purple crystals are formed because the presence of viable cells. Crystals
were dissolved in dimethyl sulfoxide (DMSO) and the optical densities (OD) of the solutions were read with a 
spectrophotometer, at a wavelength of 570 nm. Data were presented as means of OD values.
2.6. Osteogenic differentiation into the scaffolds
In order to determine osteogenesis mineralization related to calcium content of ADSCs cultured into the scaffolds
in both medium at 28 days of culture, an osteogenesis quantification assay kit (Millipore) based on Alizarin red-S
(ARS) staining dye, which binds selectively calcium salts, as reported by Perez [24]. The cell-seeded scaffolds were
examined under the optical microscope and for quantitative analysis; ARS staining dye was desorbed with the use of 
10% acetic acid, and then read at 405 nm. Data were presented as means of OD values.
3. Results and Discussion
3.1. Flow cytometry
In order to a prior characterization of ADSCs from four different donors, cells were analyzed by flow 
cytometry using cell surface markers (5 positive and 9 negative) as described above. The results are shown as 
percentage of staining. The flow cytometry analysis revealed that ADSCs expressed for all positive surface markers 
(>80%) and negative for the others (<8%), except to Anti-HLA ABC, the HLA Class I (MHC) marker, which 
presented little higher than the other negatives (Figure 2). The Anti-HLA DR, Class II MHC is the responsible for 
transplant rejection related to donors’ cells and ADSCs did not express these markers.
Figure 2. Flow citometry of adipose-derived mesenchymal stem cells incubated with positive and negative surface markers.
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3.2. Multilineage differentiation
To study the multilineage capacity of ADSCs, cells were differentiated toward the adipogenic and osteogenic 
lineages using lineage-specific induction conditions for 21 days. Osteogenic differentiation was detected by Alizarin 
Red-S staining and the adipogenic by Sudan IV, as shown in photomicrography from histological images from 2 
samples in Figure 3. The osteogenesis, based on ECM mineralization related to calcium content was observed by red-
orange histological staining, while the intracellular lipid accumulation into cytoplasmic compartment from adipogenic 
differentiation was stained by red dye. Control cultures were added to the experiment using only basic culture medium, 
where there was no cell differentiation, as observed in Figure 3.
Figure 3. Photomicrography of adipose-derived mesenchymal stem cells in osteogenic differentiation, adipogenic differentiation and no 
differentiation (control).
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3.3. Cell viability into the scaffolds
In order to evaluate the ADSCs viability into the PCL scaffolds cultured in both culture mediums (basic and 
osteogenic medium) for 14 days, MTT colorimetric assay was applied. The macroscopic images of scaffolds show the 
purple formazan cristals formed by mitochondrial activities as a result of the presence of viable cells, as observed in 
Figure 4A. After acquiring images, the purple crystal formed were dissolved from the scaffold by using DMSO and 
the optical densities (OD) of the solutions from three groups were read with a spectrophotometer, at a wavelength of 
570 nm. As observed in Figure 4B, both the groups with ADSCs cultured in basic or osteogenic medium were similar
to each other and both higher than scaffolds without cells group (control). Moreover, the authors can inferred that PCL 
scaffold was able to support cell attachment and proliferation for 12 days. 
Figure 4. Viability of adipose-derived mesenchymal stem cells into the cell-seeded PCL scaffolds. (A) Photomicrography of ADSCs attached to 
the scaffold after MTT assay. (B) Quantification of formazan crystals after dissolved them from scaffold and read with a spectrophotometer.
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3.4. Osteogenic potential of ADSCs into the scaffolds
The osteogenic assay showed the presence of a red-orange staining dye around and into the scaffold because of the 
ECM mineralization related to calcium content. The quantitative analyze showed that the PCL cell-seeded scaffolds 
cultured in osteogenic differentiation medium presented significantly greater amount of ARS staining dye when 
compared to basic medium and scaffold without cells group (Figure 5). Thus, it could be inferred that ADSC were 
viable into the scaffolds and they could differentiate toward the osteogenic lineages for 28 days in culture with 
osteogenic medium.
Figure 5. Osteogenesis of adipose-derived mesenchymal stem cells into the cell-seeded PCL scaffold. Quantification of ARS staining dye after 
dissolved them from scaffold and read with a spectrophotometer. *Statistical difference to scaffold without cells group.
4. Conclusion
       Although more tests are needed, the PCL scaffold have been great potential to be used in Tissue Engineering
associated to adipose-derived mesenchymal stem cells to bone tissue regeneration. Moreover, ADSCs had reduced
HLA expression, mainly Class II, and because of that, they might have more potential to transplantation in addition 
to osteogenic differentiation presented into the scaffolds.
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